Importantly, although LAG-3 blockade alone had a limited effect on suppressing melanoma cell growth, and SB415286 showed some inhibitor effects, their combination significantly enhanced CD8+ T cell cytolytic responses against lymphoma target cells in vitro. Here, LAG3 is linked to melanoma.